2015
DOI: 10.3892/or.2015.4090
|View full text |Cite
|
Sign up to set email alerts
|

The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma

Abstract: Abstract. BATF2 has been found to be decreased in a variety of human malignancies, while its clinical significance and functional roles in esophageal squamous cell carcinoma (ESCC) remain unknown. Herein, the aim of this study was to investigate the expression pattern and to explore the potential functions of BATF2 in ESCC tissues and cell lines. BATF2 mRNA and protein expression levels in human tissues and human ESCC cell lines were evaluated by quantitative real-time polymerase chain reaction (qRT-PCR), west… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 22 publications
0
3
0
1
Order By: Relevance
“…Interestingly, Batf2 in cancer cells has also been reported to be involved in cancer cell growth inhibition. For example, lower BATF2 expression is associated with a poor prognosis in hepatocellular carcinoma (26), oral tongue squamous cell carcinoma (27), esophageal squamous cell carcinoma (28), and medulloblastoma (29). BATF2 is down-regulated in various types of cancers and induces apoptosis (8).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, Batf2 in cancer cells has also been reported to be involved in cancer cell growth inhibition. For example, lower BATF2 expression is associated with a poor prognosis in hepatocellular carcinoma (26), oral tongue squamous cell carcinoma (27), esophageal squamous cell carcinoma (28), and medulloblastoma (29). BATF2 is down-regulated in various types of cancers and induces apoptosis (8).…”
Section: Discussionmentioning
confidence: 99%
“…The protein coded by BATF2 was shown to have an antitumor effect in a mouse model through upregulation of IL-12 p40 in tumor-associated macrophages, leading to CD8 + T-cell activation and tumor accumulation [ 27 ]. Among other cancers, BATF2 was demonstrated as a tumor suppressor of gastric cancer [ 28 ], glioblastoma [ 29 ], and esophageal squamous cell carcinoma [ 30 ]. In contrast, LY6E , the other gene found as upregulated in ASD blood samples, was suggested as a biomarker of poor prognosis in smoking-induced lung carcinogenesis [ 31 ] and colorectal cancer [ 32 ].…”
Section: Discussionmentioning
confidence: 99%
“…Abnormalities in BATF-2 and cellular communication network factor 1 (CCN1) expressions and their correlation are closely associated with malignant behaviors of colorectal cancer cells, affecting the prognosis of patients [ 9 , 10 ]. Moreover, in other tumors such as hepatocellular carcinoma (HCC) [ 11 ], non-small-cell lung cancer (NSCLC) [ 12 ], esophageal squamous cell carcinoma (ESCC) [ 13 ] and gastric cancer (GC) [ 14 ], the down-regulation of BATF-2 expression is associated with a poor prognosis. Wang et al found that BATF-2 regulated the epithelial-mesenchymal transition (EMT) and lung adenocarcinoma (LUAD) metastasis [ 15 ].…”
Section: Introductionmentioning
confidence: 99%